Showing 6631-6640 of 9381 results for "".
Spectra Peel for Acne
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/spectra-peel/19522/Demonstration of SpectraPeel for acne and rejuvenation, using pulse and Q-switched modes. Presented by Kevin Deuplechain, MDAnalyzing the Overlap Between Atopic Dermatitis, Prurigo Nodularis, and Chronic Spontaneous Urticaria
https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/analyzing-the-overlap-between-atopic-dermatitis-prurigo-nodularis-and-chronic-spontaneous-urticaria/50877/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, is joined by Editorial Board member Jason E. Hawkes, MD, MS, FAAD, to discuss three different immune-mediated inflammatory skin conditions and how understanding their mechanisms can inform optimal treatment, based on the InternationalExploring Dupilumab's Impact on Growth in Pediatric Atopic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/exploring-dupilumabs-impact-on-growth-in-pediatric-atopic-dermatitis/50962/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, and Michelle Tarbox, MD, FAAD, discuss emerging evidence and real-world experiences demonstrating how effective control of atopic dermatitis with dupilumab may support healthy growth and development in pediatric patieDermWireTV Extra: Dr. Bhatia and Dr. Schlesinger Discuss Collaboration With Oncologists
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dr-bhatia-and-dr-schlesinger-discuss-collaboration-oncologists/26304/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, and Editorial Board member Todd Schlesinger, MD, discuss the importance of collaborating with oncologists on advanced skin cancer cases as immunotherapy technology continues to progress.Sleep Disturbances and Psychological Burden of Prurigo Nodularis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/sleep-disturbances-and-psychological-burden-of-prurigo-nodularis/48790/Raj Chovatiya, MD, PhD, MSCI, FAAD, discusses the impact of itch from prurigo nodularis on quality of life through sleep disturbances and mental health effects.Science of Skincare Summit 2024:The Latest in Exosomes
https://practicaldermatology.com/conferences/science-skincare-summit-2024/science-of-skincare-summit-2024-the-latest-in-exosomes/29450/Practical Dermatology talks with Todd Schlesinger, MD, a dermatologist and Mohs surgeon, and a member of the Editorial Board, about the latest updates in exosomes and what to expect next. This video was recorded at the Science of Skincare Summit in Austin.Addressing Unmet Needs in Rare Skin Diseases
https://practicaldermatology.com/videos/c-suite-chats/addressing-unmet-needs-in-rare-skin-diseases/67376/LEO Pharma VP of Rare Disease Lukasz Jarzyna discusses an industry shift toward the massive, untapped market of unmet needs in rare skin diseases such as generalized pustular psoriasis and the current awareness campaign around that particular condition.ISDPA: Dr. Dy on JAK Inhibitors for Alopecia Areata
https://practicaldermatology.com/conferences/isdpa-midwest-derm-2024/isdpa-dr-dy-jak-inhibitors-alopecia-areata/29150/Lady Dy, MD, talks about the efficacy and safety of JAK inhibitors for treating alopecia areata at the Illinois Society of Dermatology Physician Assistants (ISDPA) Midwest Dermatology Conference 2024.Steroid Stewardship in Dermatology
https://practicaldermatology.com/programs/practical-dermatology/steroid-stewardship-in-dermatology/56794/In the first installment of this five-part series, Naiem T. Issa, MD, PhD, FAAD, and Maureen N. Offiah, MD, FAAD, discuss the importance of steroid stewardship in dermatology.Expanding Access to Care Through a Virtual Platform
https://practicaldermatology.com/videos/c-suite-chats/expanding-access-to-care-through-a-virtual-platform/69071/Patrick Burnett, MD, PhD, FAAD, Chief Medical Officer for Arcutis, discusses a new virtual health platform designed to expand access pathways to roflumilast for chronic inflammatory skin diseases.